Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.
Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, Grandvuillemin A, Mauprivez C, Lapeyre-Mestre M, Montastruc JL; French Association of PharmacoVigilance Centers.
Moulis G, et al. Among authors: veyrac g.
Eur J Intern Med. 2014 Oct;25(8):777-80. doi: 10.1016/j.ejim.2014.09.006. Epub 2014 Sep 18.
Eur J Intern Med. 2014.
PMID: 25242516